Gestational Diabetes Market Report 2026
Download Free Sample Buy Now
Gestational Diabetes Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gestational Diabetes Market Report 2026

Global Outlook – By Type (Type A1, Type A2, Other Types), By Treatment (Monitoring, Drug Treatment, Non-pharmacological Treatment), By Administration (Oral, Intravenous, Other Administrations), By End User (Hospitals, Clinics, Home Care Settings, Diagnostic Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Gestational Diabetes Market Overview

• Gestational Diabetes market size has reached to $9.11 billion in 2025

• Expected to grow to $13.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%

• Growth Driver: Impact Of Rising Obesity Rates On Healthcare Demand

• Market Trend: Advancements In Diagnostic Solutions For Early Detection Of Health Conditions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gestational Diabetes Market?

Gestational diabetes is a type of diabetes that develops during pregnancy when the body cannot produce enough insulin to regulate blood sugar levels effectively. This condition typically occurs in the second or third trimester and can affect women who have no prior history of diabetes. Gestational diabetes poses risks to both the mother and baby, including high birth weight, preterm birth, and potential development of type 2 diabetes later in life for both. It is often managed through dietary adjustments, exercise, blood sugar monitoring, and sometimes insulin therapy to ensure a healthy pregnancy and delivery.

The main types of gestational diabetes are type A1, type A2, and other types. Gestational diabetes Type A1 refers to a form of diabetes that develops during pregnancy. It is classified under gestational diabetes mellitus (GDM), which occurs when the body cannot produce enough insulin to meet the increased needs during pregnancy. The treatment involved is monitoring, drug treatment, and non-pharmacological treatment, which are taken orally, intravenously, and in other administrations. Hospitals, clinics, home care settings, and diagnostic centers use them.

Gestational Diabetes Market Global Report 2026 Market Report bar graph

What Is The Gestational Diabetes Market Size and Share 2026?

The gestational diabetes market size has grown strongly in recent years. It will grow from $9.11 billion in 2025 to $9.93 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing obesity rates, higher maternal age pregnancies, early diabetes screening programs, growth in prenatal care services, awareness of pregnancy complications.

What Is The Gestational Diabetes Market Growth Forecast?

The gestational diabetes market size is expected to see strong growth in the next few years. It will grow to $13.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising gestational diabetes prevalence, expansion of digital health monitoring, improved prenatal diagnostics, focus on preventive maternal care, healthcare policy support. Major trends in the forecast period include rising adoption of blood glucose monitoring, increased use of insulin therapy during pregnancy, growing focus on lifestyle-based disease management, expansion of prenatal screening programs, improved maternal health awareness.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gestational Diabetes Market Segmentation

1) By Type: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological Treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

What Is The Driver Of The Gestational Diabetes Market?

The increasing obese population is expected to propel the growth of the gestational diabetes market going forward. The obese population is individuals whose body mass index (BMI) is 30 or higher, indicating excessive body fat that may pose significant health risks. The obese population is rising due to a combination of sedentary lifestyles, increased consumption of high-calorie, processed foods, genetic predispositions, and limited access to healthy food and exercise options. Gestational diabetes treatment is crucial for the obese population because their higher risk of insulin resistance and excessive weight gain during pregnancy can lead to complications for both mother and baby if left unmanaged. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the increasing obese population is driving the gestational diabetes industry.

Key Players In The Global Gestational Diabetes Market

Major companies operating in the gestational diabetes market are Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd

Global Gestational Diabetes Market Trends and Insights

Major companies operating in the gestational diabetes market are focusing on developing technologically advanced products, such as diagnostic kits for gestational diabetes, to provide quick, accurate, and convenient methods for early detection. A diagnostic kit for gestational diabetes is a medical tool used to measure blood glucose levels and identify abnormal glucose tolerance in pregnant women, aiding in the early detection and management of the condition. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a diagnostic kit designed to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It accurately measures 2-hydroxybutyrate (2-HB) levels found in venous blood, naturally produced by the liver during its normal functions. Elevated 2-HB levels are associated with increased reductive stress, linked to various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any available clinical analyzer and delivers results in just 8 minutes, offering a fast and efficient diagnostic solution.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gestational Diabetes Market?

In April 2024, Digostics, a UK-based diabetes home-testing provider, partnered with AgaMatrix Europe to advance gestational diabetes screening. The partnership allows AgaMatrix to exclusively distribute Digostics' home oral glucose tolerance testing (OGTT) service, GTT@home, to the UK National Health Service (NHS), leveraging its established relationships and customer base within NHS maternity services, along with its unmatched expertise in gestational diabetes monitoring, to accelerate the product's introduction in the UK. AgaMatrix Europe is a UK-based manufacturer of blood glucose monitoring solutions.

Regional Outlook

North America was the largest region in the gestational diabetes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gestational Diabetes Market?

The gestational diabetes market consists of revenues earned by entities by providing services such as nutritional counseling, medication management, telemedicine services, lifestyle and exercise guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The gestational diabetes market also includes sales of metformin, glyburide, and insulin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gestational Diabetes Market Report 2026?

The gestational diabetes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gestational diabetes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gestational Diabetes Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $9.93 billion
Revenue Forecast In 2035 $13.85 billion
Growth Rate CAGR of 8.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment, Administration, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gestational Diabetes Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gestational Diabetes Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gestational Diabetes Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gestational Diabetes Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Blood Glucose Monitoring

4.2.2 Increased Use Of Insulin Therapy During Pregnancy

4.2.3 Growing Focus On Lifestyle-Based Disease Management

4.2.4 Expansion Of Prenatal Screening Programs

4.2.5 Improved Maternal Health Awareness

5. Gestational Diabetes Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Maternity Clinics

5.3 Diagnostic Centers

5.4 Specialty Diabetes Clinics

5.5 Homecare Providers

6. Gestational Diabetes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gestational Diabetes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gestational Diabetes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gestational Diabetes Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gestational Diabetes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gestational Diabetes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gestational Diabetes Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gestational Diabetes Market Segmentation

9.1. Global Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type A1, Type A2, Other Types

9.2. Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monitoring, Drug Treatment, Non-pharmacological Treatment

9.3. Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Other Administrations

9.4. Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Care Settings, Diagnostic Centers

9.5. Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

9.6. Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

9.7. Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pre-Gestational Diabetes, Gestational Diabetes With Complications

10. Gestational Diabetes Market Regional And Country Analysis

10.1. Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gestational Diabetes Market

11.1. Asia-Pacific Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gestational Diabetes Market

12.1. China Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gestational Diabetes Market

13.1. India Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gestational Diabetes Market

14.1. Japan Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gestational Diabetes Market

15.1. Australia Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gestational Diabetes Market

16.1. Indonesia Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gestational Diabetes Market

17.1. South Korea Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gestational Diabetes Market

18.1. Taiwan Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gestational Diabetes Market

19.1. South East Asia Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gestational Diabetes Market

20.1. Western Europe Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gestational Diabetes Market

21.1. UK Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gestational Diabetes Market

22.1. Germany Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gestational Diabetes Market

23.1. France Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gestational Diabetes Market

24.1. Italy Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gestational Diabetes Market

25.1. Spain Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gestational Diabetes Market

26.1. Eastern Europe Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gestational Diabetes Market

27.1. Russia Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gestational Diabetes Market

28.1. North America Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gestational Diabetes Market

29.1. USA Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gestational Diabetes Market

30.1. Canada Gestational Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gestational Diabetes Market

31.1. South America Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gestational Diabetes Market

32.1. Brazil Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gestational Diabetes Market

33.1. Middle East Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gestational Diabetes Market

34.1. Africa Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gestational Diabetes Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gestational Diabetes Market Regulatory and Investment Landscape

36. Gestational Diabetes Market Competitive Landscape And Company Profiles

36.1. Gestational Diabetes Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gestational Diabetes Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gestational Diabetes Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Gestational Diabetes Market Other Major And Innovative Companies

Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc

38. Global Gestational Diabetes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gestational Diabetes Market

40. Gestational Diabetes Market High Potential Countries, Segments and Strategies

40.1 Gestational Diabetes Market In 2030 - Countries Offering Most New Opportunities

40.2 Gestational Diabetes Market In 2030 - Segments Offering Most New Opportunities

40.3 Gestational Diabetes Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gestational Diabetes Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gestational Diabetes Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gestational Diabetes Market, Supply Chain Analysis
  • Table 4: Global Gestational Diabetes Market, Major Raw Material Providers
  • Table 5: Global Gestational Diabetes Market, Major Resource Providers
  • Table 6: Global Gestational Diabetes Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gestational Diabetes Market, Major Distributors And Channel Partners
  • Table 8: Global Gestational Diabetes Market, Key Technologies & Future Trends
  • Table 9: Global Gestational Diabetes Market, Major Trends
  • Table 10: Global Gestational Diabetes Market, Major End Users
  • Table 11: Global Gestational Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gestational Diabetes Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gestational Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gestational Diabetes Market - TAM, US$ Billion, 2025
  • Table 15: Global Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Gestational Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Gestational Diabetes Market - Company Scoring Matrix
  • Table 98: Sanofi S.A. Financial Performance
  • Table 99: Abbott Laboratories Financial Performance
  • Table 100: Eli Lilly and Company Financial Performance
  • Table 101: Novo Nordisk A/S Financial Performance
  • Table 102: Becton Dickinson and Company Financial Performance
  • Table 103: Global Gestational Diabetes Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Gestational Diabetes Market, Competitive Dashboard
  • Table 105: Global Gestational Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Gestational Diabetes Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gestational Diabetes Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gestational Diabetes Market, Supply Chain Analysis
  • Figure 4: Global Gestational Diabetes Market, Major Raw Material Providers
  • Figure 5: Global Gestational Diabetes Market, Major Resource Providers
  • Figure 6: Global Gestational Diabetes Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gestational Diabetes Market, Major Distributors And Channel Partners
  • Figure 8: Global Gestational Diabetes Market, Key Technologies & Future Trends
  • Figure 9: Global Gestational Diabetes Market, Major Trends
  • Figure 10: Global Gestational Diabetes Market, Major End Users
  • Figure 11: Global Gestational Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gestational Diabetes Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gestational Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gestational Diabetes Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gestational Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Gestational Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Gestational Diabetes Market - Company Scoring Matrix
  • Figure 98: Sanofi S.A. Financial Performance
  • Figure 99: Abbott Laboratories Financial Performance
  • Figure 100: Eli Lilly and Company Financial Performance
  • Figure 101: Novo Nordisk A/S Financial Performance
  • Figure 102: Becton Dickinson and Company Financial Performance
  • Figure 103: Global Gestational Diabetes Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Gestational Diabetes Market, Competitive Dashboard
  • Figure 105: Global Gestational Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Gestational Diabetes Market Size Gain ($ Billion), Segmentation By Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Instant Tea Premix Market Report 2026 - Global Outlook – By Product type (Cardamom Tea Premix, Ginger Tea Premix, Masala Tea Premix, Lemon Tea Premix, Plain Tea Premix, Lemon Grass Tea Premix), By Nature (Organic Tea Pre...

Type 1 Diabetes Market Report 2026 - Global Outlook – By Product Type (Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types), By Device (Insulin Pump, Insulin Pen, Blood...

Insuman Market Report 2026 - Epidemiology, Pipeline Analysis, Market Insights & Forecasts...

Type 2 Diabetes Market Report 2026 - Global Outlook – By Drug Class (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfony...

Clinical Nutrition For Diabetes Care Market Report 2026 - Global Outlook – By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Insti...

Diabetic Foods Market Report 2026 - Global Outlook – By Product Type (Bakery Products, Dairy Products, Confectionery Products, Beverages, Snacks, Other Product Types ), By Distribution Channel (Supermarkets And Hypermark...

Continous Blood Glucose Monitoring Global Market Report 2023 – By Component (Insulin Pumps, Sensors, Transmitters, Receivers), By Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Cri...

Diabetes Care Devices Market 2022 - By Type (Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, Insulin Pens, Syringes, Pumps And Injectors), By Type Of Expenditure (Public, Private), By E...

Frequently Asked Questions

The Gestational Diabetes market was valued at $9.11 billion in 2025, increased to $9.93 billion in 2026, and is projected to reach $13.85 billion by 2030.

The global Gestational Diabetes market is expected to grow at a CAGR of 8.7% from 2026 to 2035 to reach $13.85 billion by 2035.

Some Key Players in the Gestational Diabetes market Include, Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd .

Major trend in this market includes: Advancements In Diagnostic Solutions For Early Detection Of Health Conditions. For further insights on this market. request a sample here

North America was the largest region in the gestational diabetes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us